289 related articles for article (PubMed ID: 27211516)
1. Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.
Legge SE; Hamshere M; Hayes RD; Downs J; O'Donovan MC; Owen MJ; Walters JTR; MacCabe JH
Schizophr Res; 2016 Jul; 174(1-3):113-119. PubMed ID: 27211516
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of clozapine prescribing.
Gee SH; Shergill SS; Taylor DM
J Psychopharmacol; 2018 May; 32(5):552-558. PubMed ID: 29692222
[TBL] [Abstract][Full Text] [Related]
3. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients.
Davis MC; Fuller MA; Strauss ME; Konicki PE; Jaskiw GE
Acta Psychiatr Scand; 2014 Jul; 130(1):30-9. PubMed ID: 24299466
[TBL] [Abstract][Full Text] [Related]
5. Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia.
Ucok A; Yağcıoğlu EA; Yıldız M; Kaymak SU; Saka MC; Taşdelen R; Danacı AE; Şenol ŞH
Psychiatry Res; 2019 May; 275():149-154. PubMed ID: 30908979
[TBL] [Abstract][Full Text] [Related]
6. Predictors of clozapine discontinuation in patients with schizophrenia.
Krivoy A; Malka L; Fischel T; Weizman A; Valevski A
Int Clin Psychopharmacol; 2011 Nov; 26(6):311-5. PubMed ID: 21849905
[TBL] [Abstract][Full Text] [Related]
7. Clozapine use in a forensic population in a New South Wales prison hospital.
Martin A; O'Driscoll C; Samuels A
Aust N Z J Psychiatry; 2008 Feb; 42(2):141-6. PubMed ID: 18197509
[TBL] [Abstract][Full Text] [Related]
8. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
[TBL] [Abstract][Full Text] [Related]
10. Clozapine use in early psychosis.
Thien K; Bowtell M; Eaton S; Bardell-Williams M; Downey L; Ratheesh A; McGorry P; O'Donoghue B
Schizophr Res; 2018 Sep; 199():374-379. PubMed ID: 29525463
[TBL] [Abstract][Full Text] [Related]
11. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study.
Nyakyoma K; Morriss R
Psychopharmacol Bull; 2010; 43(2):67-81. PubMed ID: 21052043
[TBL] [Abstract][Full Text] [Related]
13. Clozapine treatment and discontinuation in Iceland: A national longitudinal study using electronic patient records.
Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
Nord J Psychiatry; 2016 Aug; 70(6):450-5. PubMed ID: 27049594
[TBL] [Abstract][Full Text] [Related]
14. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
[TBL] [Abstract][Full Text] [Related]
15. The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.
Miodownik C; Lerner V; Kibari A; Toder D; Cohen H
J Clin Psychiatry; 2006 Aug; 67(8):1204-8. PubMed ID: 16965197
[TBL] [Abstract][Full Text] [Related]
16. Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophrenia.
Iruretagoyena B; Castañeda CP; Mena C; Diaz C; Nachar R; Ramirez-Mahaluf JP; González-Valderrama A; Undurraga J; Maccabe JH; Crossley NA
Schizophr Res; 2021 Sep; 235():102-108. PubMed ID: 34340062
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
[TBL] [Abstract][Full Text] [Related]
18. Is the risk of antipsychotic polypharmacy discontinuation dependent on the agents used?
Constantine RJ; Andel R; McPherson M; Tandon R
Psychiatry Res; 2018 May; 263():238-244. PubMed ID: 29195836
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of treatment-resistant psychoses in the community: A naturalistic study.
Beck K; McCutcheon R; Stephenson L; Schilderman M; Patel N; Ramsay R; Howes OD
J Psychopharmacol; 2019 Oct; 33(10):1248-1253. PubMed ID: 31241396
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia.
Stroup TS; Gerhard T; Crystal S; Huang C; Olfson M
Am J Psychiatry; 2016 Feb; 173(2):166-73. PubMed ID: 26541815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
